What if a type 2 diabetes diagnosis could be the start of taking better care of your health—not the end of it?

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus share their top 10 tips for people newly diagnosed with type 2 diabetes, with a focus on helping you feel informed, supported, and encouraged. They talk about why this diagnosis is not a personal failure, how much of it is connected to genetics and metabolism, and why early understanding can make a meaningful difference.

The conversation is grounded, hopeful, and focused on what’s possible. Steve and Jeremy walk through simple, realistic steps that can help you feel more in control—without pressure to be perfect. They cover everything from understanding how your body works to building habits that fit into your everyday life, along with the growing number of tools and treatments that can support you along the way.

The takeaway is clear: this diagnosis can feel overwhelming at first, but it can also be a turning point. With time, support, and the right approach, you can improve your health and continue living a full, active life.

Key Topics
• Why type 2 diabetes is not your fault
• Understanding insulin resistance and disease progression
• Why early action matters
• Focusing on weight with realistic expectations
• The role of GLP-1 medications in early treatment
• Exercise and movement as part of daily life
• Learning how food affects your body
• Using blood sugar monitoring in a practical way
• Taking medications consistently
• Protecting your heart early
• The importance of routine screenings and labs
• Building a strong and supportive care team

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

What does someone really need to know in the first days and weeks after a type 1 diabetes diagnosis?

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus share the “starter kit” they wish every newly diagnosed person and family had from the very beginning. Both diagnosed with type 1 diabetes at age 15, Steve and Jeremy reflect on what has changed since their own diagnoses and walk through the practical advice, emotional reassurance, and foundational education that can make this transition a little less overwhelming.

The conversation covers everything from the typical emotional reaction to a diagnosis to the importance of early diabetes education, starting insulin, using a CGM as soon as possible, and setting realistic blood sugar goals. They also talk about the honeymoon phase, how to keep doing the things you love, why support systems matter, how to find the right provider, and what newly diagnosed families should know about clinical trials and preserving beta cell function.

This episode is a reminder that while a new diagnosis can feel like your world has been turned upside down, people with type 1 diabetes can live long, healthy, full lives—and that no one has to figure it all out alone.

Key Topics

• Why it’s okay to feel overwhelmed after diagnosis

• The importance of diabetes education right away

• Understanding the honeymoon phase

• Basal and bolus insulin basics

• Why CGM should be started early

• Realistic A1C and time-in-range goals

• Keeping up with the things you love

• Involving family, friends, and support networks

• Finding the right diabetes provider

• Considering clinical trials after diagnosis

• Food, carb counting, and keeping things simple

• Staying positive and looking ahead

Are you getting the most out of the diabetes technology you use every day and do you know what’s coming next?

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with diabetes tech expert Justin Eastzer, creator of Diabetech, who is also living with type 1 diabetes, for a conversation about the steadily growing and expanding world of diabetes technology. They talk about how CGMs, automated insulin delivery systems, connected apps, and wearable displays are continuing to improve the way people with type 1 diabetes manage glucose in daily life.

Justin shares his diagnosis story, including being initially treated for type 2 diabetes before learning he had type 1, and how the online diabetes community helped him find the right answers. That experience led him to build a platform dedicated to reviewing devices, following industry developments, and helping people better understand the technology available today.

The discussion explores the current landscape of automated insulin delivery systems, practical differences between pumps, and the growing ecosystem of apps, displays, and data tools that allow people to interact with their glucose data in real time. They also look ahead at what’s coming next in diabetes tech, including new pump designs, smarter algorithms, improved connectivity, and continued efforts to reduce the day-to-day workload of living with type 1 diabetes.

Key Topics
• Why many people only use part of their diabetes tech’s capabilities
• Justin’s journey to a type 1 diabetes diagnosis
• Making pumps, CGMs, and apps work in everyday life
• Comparing automated insulin delivery systems
• Tubed vs. tubeless pump considerations
• The importance of optimizing personal settings
• Progress over perfection with time in range
• Reducing diabetes burnout through technology
• Helpful apps, displays, and tech hacks
• Where diabetes technology is heading next

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

What does it really look like to grow older with type 1 diabetes today?

The good news is people with diabetes are now living longer than ever! In this episode, Dr. Steve Edelman is joined by diabetes advocate Joanne Milo and endocrinologist Dr. Athena Tsimikas to talk about the realities of aging with type 1. They share how expectations have changed over time, why more people are now living long lives with diabetes, and what it takes to stay safe, independent, and supported through the aging process. The conversation covers changing insulin needs, screening for vision, hearing, and cognitive health, the role of technology, and the importance of community and care partners.

They also discuss the emotional side of aging with diabetes, including the need to feel heard, understood, and safe while continuing to live a full and meaningful life.

Key Topics
• Living longer with type 1: how expectations have changed
• Changing insulin sensitivity, muscle mass, and dosing over time
• Preventing falls: vision, neuropathy, and mobility considerations
• Cognitive health and why screening matters
• Technology in older adults: CGM and hybrid closed-loop benefits
• Medication considerations for heart and kidney protection
• The role of care partners and support systems
• Emotional health: fear, independence, and being understood
• Staying active, social, and engaged while aging with diabetes
• Advocacy and preparing for the future

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

What does it take to safely manage type 1 diabetes while flying a commercial jet?

In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman talk with Quinton Weiskittel, a commercial pilot living with type 1 diabetes. Quinton shares what it was like to be diagnosed mid-career, how FAA rules have changed, and the real-world routines he uses to stay steady through long flights, time zones, busy airports, and long stretches of sitting.

They also cover what the FAA requires for certification, how Quinton uses CGM data and smart “buffer” strategies to prevent lows, and why he’s chosen MDI over pump therapy while flying.

Key Topics

• Being diagnosed with diabetes mid-career: the moment everything changed
• FAA rules on pilots with diabetes and the path back to the cockpit
• CGM targets, reporting requirements, and medical follow-ups as a pilot with diabetes
• Preventing lows during flights: alerts, trends, and planning ahead
• Food choices and low-carb strategies while flying a plane
• What coworkers need to know (CGM alarms, injections, and professionalism)
• Travel tips for diabetes: airports,travel lulls and wait time, and insulin logistics
• Pump therapy in the air: pressure concerns and practical tradeoffs
• Advocacy and finding the right endocrinology support
• Life perspective: staying grounded while chasing big goals

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

What new advancements are actually coming in diabetes care in 2026 and what’s in store in the near future? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus both take a look at the diabetes treatments and technologies they believe are most likely to arrive in 2026.

Together, they walk through emerging therapies for both type 1 and type 2 diabetes, focusing on developments that are no longer theoretical but actively moving through late-stage trials and regulatory review. The conversation covers disease-modifying treatments, next-generation medications, and technology advances that could meaningfully change daily diabetes management.

Key Topics:

• Disease-Modifying Therapies for T1D: Preserving beta cell function after T1D diagnosis and why this represents a major shift in treatment goals.
• New Medications for Type 2 Diabetes: Oral GLP-1s, dual- and triple-agonist therapies, and what they may offer beyond current options.
• GLP-1s in Type 1 Diabetes: Where the research stands, off-label use today, and what future approvals could look like.
• Once-Weekly Basal Insulin: Why it’s promising for type 2 diabetes and who it’s best suited for.
• Inhaled Insulin Updates: New dosing guidance and expanded use cases.
• Continuous Ketone Monitoring: How this technology could improve safety and open doors for additional therapies in T1D.
• Cure-Oriented Research: Stem cell and gene therapy approaches that aim to restore insulin production.
• The Big Picture in 2026: Why 2026 represents real momentum — and what it could mean for access, outcomes, and quality of life.

We also created an article on this topic - READ IT HERE!

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate

Why did the FDA deny sotagliflozin —even with strong data showing heart, kidney, and glucose benefits? In this episode, Dr. Steve Edelman sits down with special guest Stacey Simms to break down the full story behind SGLT inhibitors and their complicated path in type 1 diabetes.

Together, they walk through how SGLT inhibitors transformed type 2 diabetes care, why many clinicians believe people with type 1 should have access, and how the risk of DKA shaped the FDA’s decision. Dr. Edelman also shares insights on who might benefit, how to reduce risk, and why continuous ketone monitoring could be a game-changer for future approvals.

They also touch on the growing discussion around GLP-1 medications in type 1 diabetes, new study results, and what emerging evidence could mean for future treatment options.

In this episode:

• Sotagliflozin & SGLT Inhibitors in T1D: Why these medications matter and what the latest data shows.
• The FDA Denial: Understanding the DKA concerns and why approval remains challenging.
• Real-World Experience: How clinicians are using SGLT inhibitors safely today in select patients.
• Continuous Ketone Monitoring: Why dual-analyte sensors could unlock safer use in T1D.
• GLP-1s in Type 1 Diabetes: What recent research reveals about potential benefits.
• Who Might Benefit Most: Kidney protection, heart health, and metabolic improvements.
• Looking Ahead: How ongoing studies and patient advocacy could shape future guidelines

Learn more about Diabetes Connections with Stacey Simms: diabetes-connections.com

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: tcoyd.org
Blog: tcoyd.org/blog
Podcast: tcoydthepodcast.transistor.fm
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: tcoyd.org/donate